Global ENT devices market was valued at USD 20.7 million in 2020. It is expected to grow at a compound annual growth rate (CAGR of 4.7%) between 2021 and 2028. Market growth is being driven by key trends such as the growing geriatric population, rising prevalence of ENT-related diseases, and increasing penetration of minimally invasive ENT techniques. The market's growth is also influenced by technological advancements.
Due to their high cost, there is little demand for advanced ENT systems and devices in developing countries. This is because they are more widely used in developed economies like the U.S. Market penetration will be significantly improved by increasing healthcare spending and rising per capita income. Due to the high prevalence of ENT diseases such as sinusitis and hearing loss, sales are expected to rise rapidly in developing countries. There is also an increased effort to improve access to healthcare facilities.
In industrialized countries, hearing loss/impairment is one of the most common conditions among patients. The WHO estimates that over 460 million people in the world have disabling hearing loss. This is approximately 5% of the global population. It is projected that this number will rise to over 900 millions by 2050, or 1 in 10 people. This is due to two main factors: increasing life expectancy and increased noise pollution. More cases of hearing loss in older people. Low-income countries are also susceptible to infections such as meningitis, middle ear infection, and measles. Hearing impairment can also be caused by chronic inflammation, noise exposure and vascular disorders.
Pandemic Impact |
Outlook after COVID |
In 2020's worst months, ENT clinics were closed in large numbers and elective procedures were canceled at hospitals. This led to a drop in sales. |
In the next few years, growth will be boosted by the resumption or business operations within the guidelines. |
The entire industry was affected by the restrictions on movement in many markets. Audiology stores, which are the main consumer channel for hearing care products and services, have either been closed or had their hours reduced. |
The market conditions were different in each region. ENT-related surgeries volumes recovered quickly in the U.S. and China, Germany & Australia, while they recover slowly in Spain, England, and Italy. Demand for ENT devices will rise as ENT-related surgery volumes increase. |
Karl Storz is a leader in ENT devices that are minimally invasive. It offers HD video rhino-laryngoscopes that can be used to visualize the nose, pharynx and larynx with HD image quality. Ambu, Inc. offers single-use rhinolaryngoscopes that are an alternative to reusable scopes. The company was awarded CE Mark in March 2019 for Ambu aScope4 RhinoLaryngo Slim.
The market's largest segment, diagnostic ENT devices, accounted for 28.3% of the highest revenue share in 2020. This is due to the availability and dominance of market leaders. Hill-Rom is one of the major players on the market that offers diagnostic ENT devices. ; Karl Storz GmbH & Co KG; MAICO Diagnostics GmbH; BioMed Jena GmbH; PATH medical GmbH; Fujifilm Corporation; Ambu A/S Smith; Nephew PLC. ; iHEARmedical, Inc., Veran Medical Technologies, and Hedera Biomedics S.r.l.
These players are known for their innovative growth strategies, which include product launches and mergers or acquisitions. In July 2017, PENTAX Medical -a HOYA Division and Shanghai Aohua Photoelectricity Endoscope Co. Ltd. announced a joint venture in order to develop products in flexible medical endoscopy.
The segment of hearing aids is expected to grow at the fastest pace during the forecast period. This is due to the entry of new players, increased adoption of these devices and technological advances due to market players investing more in R&D. Starkey Hearing Technologies launched Livio Edge AI in February 2020. This product combines both sound processing and sound quality for challenging listening environments.
North America dominated the market in ENT devices, accounting for 36.0% of the total market share. The high number of ENT-related diseases in the region, increased demand for hearing aids, large hospitals and well-equipped ambulatory facilities and a large target population can all explain this dominance. The market's dominance is also due to the presence of important market players and supportive government regulations regarding portable medical devices.
The market in Europe accounted for the second largest revenue share in 2020. Because of its well-established healthcare infrastructure, and high patient awareness, the region is high in hearing aid penetration. Asia Pacific is expected to grow at the fastest pace during the forecast period. This is due to increased awareness regarding early diagnosis and growing healthcare spending, as well as rising investment by market players. Olympus Corporation, a Japan company, introduced ENFVT3 in May 2018. This rhino-laryngo-laryngo camerascope integrates 4-direction angulation.
Some of the most emerging countries in Asia Pacific include South Korea, Australia, Thailand, Thailand, and Australia. The ENT market is expected to grow due to technological advancements such as wireless monitoring and real-time monitoring.
Market players adopt key strategies such as acquisitions, partnerships and the launch new products. WIDEX MOMENT, the first hearing aids to sound natural, was launched by WS Audiology in March 2020. Widex's ZeroDelay Technology is responsible for this. Cochlear Limited and GN Hearing announced support for streaming directly from Android devices to hearing aids using Bluetooth Low Energy (BLE) in September 2019. The market leader in ENT devices is:
Demant A/S
Sonova
Ambu A/S
Pentax Medical
Karl Storz
Olympus Corporation
Richard Wolf Gmbh
Widex
Cochlear Ltd.
Sivantos, Inc.
Starkey Hearing Technologies
Gn Resound A/S
Rion Co., Ltd.
Welch Allyn
Atos Medical AB
Up Market Research published a new report titled “ENT Devices Market research report which is segmented by Product (Hearing Implants, Nasal Splints, Surgical Devices, Hearing Aids, Diagnostic Devices), By Players/Companies Cochlear Ltd, Atos Medical AB, Pentax Medical, Starkey Hearing Technologies, Olympus Corporation, Rion Co Ltd, Gn Resound A/S, Welch Allyn, Ambu A/S, Widex, Richard Wolf Gmbh, Karl Storz, Demant A/S, Sonova, Sivantos Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | ENT Devices Market Research Report |
By Product | Hearing Implants, Nasal Splints, Surgical Devices, Hearing Aids, Diagnostic Devices |
By Companies | Cochlear Ltd, Atos Medical AB, Pentax Medical, Starkey Hearing Technologies, Olympus Corporation, Rion Co Ltd, Gn Resound A/S, Welch Allyn, Ambu A/S, Widex, Richard Wolf Gmbh, Karl Storz, Demant A/S, Sonova, Sivantos Inc |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 217 |
Number of Tables & Figures | 152 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Product (Hearing Implants, Nasal Splints, Surgical Devices, Hearing Aids, Diagnostic Devices).
ENT Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the ENT Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the ENT Devices Market Report:
Some other reports from this category!